Rectal Adenocarcinoma Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
- Rectal Adenocarcinoma
- +2 more
- Capecitabine
- +6 more
- Birmingham, Alabama
- +649 more
2022-04-05
Apr 5, 2022N
Active, not recruiting
- Locally Advanced Rectal Adenocarcinoma
- +9 more
- Capecitabine
- +5 more
- Houston, TexasM D Anderson Cancer Center
2022-03-23
Mar 23, 2022P
Active, not recruiting
- Rectal Adenocarcinoma
- LY2157299
- +3 more
- Portland, OregonProvidence Cancer Center
2022-03-22
Mar 22, 2022E
Recruiting
- Ovarian Cancer
- +68 more
- Phoenix, Arizona
- +6 more
2022-03-21
Mar 21, 2022H
Recruiting
- Rectal Adenocarcinoma
- Capecitabine
- +2 more
- Tampa, FloridaMoffitt Cancer Center
2022-03-18
Mar 18, 2022A
Active, not recruiting
- Rectal Cancer
- +2 more
- Aalborg, DenmarkAalborg University Hospital
2022-03-01
Mar 1, 2022M
Not yet recruiting
- Rectal Adenocarcinoma
- +8 more
- Chemotherapy
- +3 more
- Houston, TexasM D Anderson Cancer Center
2022-02-25
Feb 25, 2022M
Completed
- Rectal Adenocarcinoma
- +4 more
- Quality-of-Life Assessment
- +2 more
- Scottsdale, Arizona
- +1 more
2022-02-18
Feb 18, 2022N
Suspended
- Locally Advanced Rectal Carcinoma
- +9 more
- Capecitabine
- +2 more
- Los Angeles, California
- +7 more
2022-02-04
Feb 4, 2022M
Recruiting
- Rectal Adenocarcinoma
- +4 more
- TSR-042
- +2 more
- Basking Ridge, New Jersey
- +6 more
2022-01-28
Jan 28, 2022J
Recruiting
- Locally Advanced Rectal Carcinoma
- +9 more
- Capecitabine
- +7 more
- Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
2022-01-13
Jan 13, 2022A
Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer
Active, not recruiting
- Colon Adenocarcinoma
- +8 more
- Clobetasol Propionate
- +3 more
- Phoenix, Arizona
- +21 more
2022-01-05
Jan 5, 2022M
Active, not recruiting
- Colon Adenocarcinoma
- +10 more
- Anti-PD-L1/TGFbetaRII Fusion Protein M7824
- Houston, TexasM D Anderson Cancer Center
2022-01-12
Jan 12, 2022S
Recruiting
- Colon Adenocarcinoma
- +18 more
- Cetuximab
- +5 more
- Anchorage, Alaska
- +798 more
2022-01-06
Jan 6, 2022H
Completed
- Rectal Cancer
- Rectal Adenocarcinoma
- Lenvatinib
- +2 more
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-12-27
Dec 27, 2021U
Recruiting
- Colorectal Adenocarcinoma
- +6 more
- Aurora, Colorado
- +4 more
2021-11-19
Nov 19, 2021M
Active, not recruiting
- Colon Adenocarcinoma
- +2 more
- Biospecimen Collection
- +3 more
- Conroe, Texas
- +4 more
2021-11-30
Nov 30, 2021U
Withdrawn
- Rectal Adenocarcinoma
- Chemoradiation
- +4 more
- Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
2021-11-02
Nov 2, 2021U
Terminated
- Rectal Adenocarcinoma
- FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}
- Low dose fractionated radiation therapy (LDFRT)
- Baltimore, MarylandUmmc Msgcc
2021-10-06
Oct 6, 2021O
Recruiting
- Rectal Adenocarcinoma
- +6 more
- 3-Dimensional Conformal Radiation Therapy
- +2 more
- Portland, OregonOHSU Knight Cancer Institute
2021-11-01
Nov 1, 2021O
Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
Recruiting
- Rectal Adenocarcinoma
- +8 more
- Biopsy
- +2 more
- Portland, OregonOHSU Knight Cancer Institute
2021-10-04
Oct 4, 2021F
Recruiting
- Colonic Neoplasms
- +4 more
- CADe colonoscopy using GI Genius device
- Brescia, ItalyFondazione Poliambulanza Istituto Ospedaliero
2021-09-22
Sep 22, 2021U
Active, not recruiting
- Parastomal Hernia
- +2 more
- Intervention group
- Helsinki, Finland
- +6 more
2021-08-10
Aug 10, 2021M
Recruiting
- Rectal Adenocarcinoma
- Capecitabine
- +5 more
- Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
2021-07-14
Jul 14, 2021V
Completed
- Mucinous Adenocarcinoma of the Rectum
- +9 more
- intensity-modulated radiation therapy
- +4 more
- Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
2021-07-19
Jul 19, 2021